Essential Emergency and Critical Care : a consensus among global clinical experts
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ..
BACKGROUND: Globally, critical illness results in millions of deaths every year. Although many of these deaths are potentially preventable, the basic, life-saving care of critically ill patients are often overlooked in health systems. Essential Emergency and Critical Care (EECC) has been devised as the care that should be provided to all critically ill patients in all hospitals in the world. EECC includes the effective care of low cost and low complexity for the identification and treatment of critically ill patients across all medical specialties. This study aimed to specify the content of EECC and additionally, given the surge of critical illness in the ongoing pandemic, the essential diagnosis-specific care for critically ill patients with COVID-19.
METHODS: In a Delphi process, consensus (>90% agreement) was sought from a diverse panel of global clinical experts. The panel iteratively rated proposed treatments and actions based on previous guidelines and the WHO/ICRC's Basic Emergency Care. The output from the Delphi was adapted iteratively with specialist reviewers into a coherent and feasible package of clinical processes plus a list of hospital readiness requirements.
RESULTS: The 269 experts in the Delphi panel had clinical experience in different acute medical specialties from 59 countries and from all resource settings. The agreed EECC package contains 40 clinical processes and 67 requirements, plus additions specific for COVID-19.
CONCLUSION: The study has specified the content of care that should be provided to all critically ill patients. Implementing EECC could be an effective strategy for policy makers to reduce preventable deaths worldwide.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2021 |
|---|---|
| Erschienen: |
2021 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:6 |
|---|---|
| Enthalten in: |
BMJ global health - 6(2021), 9 vom: 21. Sept. |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Schell, Carl Otto [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
COVID-19 |
|---|
| Anmerkungen: |
Date Completed 30.09.2021 Date Revised 14.02.2024 published: Print Citation Status MEDLINE |
|---|
| doi: |
10.1136/bmjgh-2021-006585 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM330901885 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM330901885 | ||
| 003 | DE-627 | ||
| 005 | 20240214232341.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231225s2021 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1136/bmjgh-2021-006585 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1292.xml |
| 035 | |a (DE-627)NLM330901885 | ||
| 035 | |a (NLM)34548380 | ||
| 035 | |a (PII)e006585 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Schell, Carl Otto |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Essential Emergency and Critical Care |b a consensus among global clinical experts |
| 264 | 1 | |c 2021 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 30.09.2021 | ||
| 500 | |a Date Revised 14.02.2024 | ||
| 500 | |a published: Print | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a © Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ. | ||
| 520 | |a BACKGROUND: Globally, critical illness results in millions of deaths every year. Although many of these deaths are potentially preventable, the basic, life-saving care of critically ill patients are often overlooked in health systems. Essential Emergency and Critical Care (EECC) has been devised as the care that should be provided to all critically ill patients in all hospitals in the world. EECC includes the effective care of low cost and low complexity for the identification and treatment of critically ill patients across all medical specialties. This study aimed to specify the content of EECC and additionally, given the surge of critical illness in the ongoing pandemic, the essential diagnosis-specific care for critically ill patients with COVID-19 | ||
| 520 | |a METHODS: In a Delphi process, consensus (>90% agreement) was sought from a diverse panel of global clinical experts. The panel iteratively rated proposed treatments and actions based on previous guidelines and the WHO/ICRC's Basic Emergency Care. The output from the Delphi was adapted iteratively with specialist reviewers into a coherent and feasible package of clinical processes plus a list of hospital readiness requirements | ||
| 520 | |a RESULTS: The 269 experts in the Delphi panel had clinical experience in different acute medical specialties from 59 countries and from all resource settings. The agreed EECC package contains 40 clinical processes and 67 requirements, plus additions specific for COVID-19 | ||
| 520 | |a CONCLUSION: The study has specified the content of care that should be provided to all critically ill patients. Implementing EECC could be an effective strategy for policy makers to reduce preventable deaths worldwide | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Research Support, Non-U.S. Gov't | |
| 650 | 4 | |a COVID-19 | |
| 650 | 4 | |a health policy | |
| 650 | 4 | |a health services research | |
| 650 | 4 | |a health systems | |
| 650 | 4 | |a surgery | |
| 700 | 1 | |a Khalid, Karima |e verfasserin |4 aut | |
| 700 | 1 | |a Wharton-Smith, Alexandra |e verfasserin |4 aut | |
| 700 | 1 | |a Oliwa, Jacquie |e verfasserin |4 aut | |
| 700 | 1 | |a Sawe, Hendry R |e verfasserin |4 aut | |
| 700 | 1 | |a Roy, Nobhojit |e verfasserin |4 aut | |
| 700 | 1 | |a Sanga, Alex |e verfasserin |4 aut | |
| 700 | 1 | |a Marshall, John C |e verfasserin |4 aut | |
| 700 | 1 | |a Rylance, Jamie |e verfasserin |4 aut | |
| 700 | 1 | |a Hanson, Claudia |e verfasserin |4 aut | |
| 700 | 1 | |a Kayambankadzanja, Raphael K |e verfasserin |4 aut | |
| 700 | 1 | |a Wallis, Lee A |e verfasserin |4 aut | |
| 700 | 1 | |a Jirwe, Maria |e verfasserin |4 aut | |
| 700 | 1 | |a Baker, Tim |e verfasserin |4 aut | |
| 700 | 0 | |a EECC Collaborators |e verfasserin |4 aut | |
| 700 | 0 | |a EECC Collaborators* |e verfasserin |4 aut | |
| 700 | 1 | |a Asghar, Adam |e investigator |4 oth | |
| 700 | 1 | |a Laytin, Adam D |e investigator |4 oth | |
| 700 | 1 | |a Holloway, Adrian J |e investigator |4 oth | |
| 700 | 1 | |a Adib, Ahmed Rhassane El |e investigator |4 oth | |
| 700 | 1 | |a Michaelides, Alexia |e investigator |4 oth | |
| 700 | 1 | |a Munoz, Alvaro Coronado |e investigator |4 oth | |
| 700 | 1 | |a Muzuka, Amos |e investigator |4 oth | |
| 700 | 1 | |a Fernández, Analía |e investigator |4 oth | |
| 700 | 1 | |a Pembe, Andrea B |e investigator |4 oth | |
| 700 | 1 | |a Wellhagen, Andreas |e investigator |4 oth | |
| 700 | 1 | |a Smith, Andrew G |e investigator |4 oth | |
| 700 | 1 | |a Gadgil, Anita |e investigator |4 oth | |
| 700 | 1 | |a Hvarfner, Anna |e investigator |4 oth | |
| 700 | 1 | |a Abayadeera, Anuja |e investigator |4 oth | |
| 700 | 1 | |a Agulnik, Asya |e investigator |4 oth | |
| 700 | 1 | |a Godard, Aurélie |e investigator |4 oth | |
| 700 | 1 | |a Venkatesh, Balasubramanian |e investigator |4 oth | |
| 700 | 1 | |a Yousif, Bargo Mahamat |e investigator |4 oth | |
| 700 | 1 | |a Ben Morton, Bhakti Sarang |e investigator |4 oth | |
| 700 | 1 | |a Kumar, Bharath |e investigator |4 oth | |
| 700 | 1 | |a Vijayaraghavan, Tirupakuzhi |e investigator |4 oth | |
| 700 | 1 | |a King, Bobby |e investigator |4 oth | |
| 700 | 1 | |a Rice, Brian |e investigator |4 oth | |
| 700 | 1 | |a Louise Thwaites, C |e investigator |4 oth | |
| 700 | 1 | |a Tai, Chian Wern |e investigator |4 oth | |
| 700 | 1 | |a Owoo, Christian |e investigator |4 oth | |
| 700 | 1 | |a Sendagire, Cornelius |e investigator |4 oth | |
| 700 | 1 | |a Petersen, Dan Brun |e investigator |4 oth | |
| 700 | 1 | |a Tatay, Daniel |e investigator |4 oth | |
| 700 | 1 | |a Skinner, David Lee |e investigator |4 oth | |
| 700 | 1 | |a Kinyua, Denis |e investigator |4 oth | |
| 700 | 1 | |a Ghosh, Dhruva |e investigator |4 oth | |
| 700 | 1 | |a Aryal, Diptesh |e investigator |4 oth | |
| 700 | 1 | |a Mlombwa, Donald |e investigator |4 oth | |
| 700 | 1 | |a Thi, Duyen |e investigator |4 oth | |
| 700 | 1 | |a Bui, Hanh |e investigator |4 oth | |
| 700 | 1 | |a Lugazia, Edwin R |e investigator |4 oth | |
| 700 | 1 | |a Riviello, Elisabeth |e investigator |4 oth | |
| 700 | 1 | |a Molyneux, Elizabeth M |e investigator |4 oth | |
| 700 | 1 | |a Heyns, Ellena |e investigator |4 oth | |
| 700 | 1 | |a Nsutebu, Emmanuel Fru |e investigator |4 oth | |
| 700 | 1 | |a Montalvo, Erika |e investigator |4 oth | |
| 700 | 1 | |a Moreno, Ernesto Gerardo |e investigator |4 oth | |
| 700 | 1 | |a Kanyangira, Esther Banda |e investigator |4 oth | |
| 700 | 1 | |a Muttalib, Fiona |e investigator |4 oth | |
| 700 | 1 | |a Mupeta, Francis |e investigator |4 oth | |
| 700 | 1 | |a Diaz, Franco |e investigator |4 oth | |
| 700 | 1 | |a Bulamba, Fred |e investigator |4 oth | |
| 700 | 1 | |a Nzanzu, Furaha |e investigator |4 oth | |
| 700 | 1 | |a Pascal, Blaise |e investigator |4 oth | |
| 700 | 1 | |a Wooldridge, Gavin |e investigator |4 oth | |
| 700 | 1 | |a Mwakisambwe, Gibonce |e investigator |4 oth | |
| 700 | 1 | |a Richards, Guy A |e investigator |4 oth | |
| 700 | 1 | |a Ammar, Hala |e investigator |4 oth | |
| 700 | 1 | |a Mangat, Halinder S |e investigator |4 oth | |
| 700 | 1 | |a Ghali, Hasanein H |e investigator |4 oth | |
| 700 | 1 | |a Shah, Hiral A |e investigator |4 oth | |
| 700 | 1 | |a Shum, Hoi Ping |e investigator |4 oth | |
| 700 | 1 | |a Abdullahi, Ibrahim Salim |e investigator |4 oth | |
| 700 | 1 | |a Martin-Loeches, Ignacio |e investigator |4 oth | |
| 700 | 1 | |a von der Osten, Ingrid T |e investigator |4 oth | |
| 700 | 1 | |a Mcknight, Jacob |e investigator |4 oth | |
| 700 | 1 | |a Lee, James S |e investigator |4 oth | |
| 700 | 1 | |a Namagga, Jane Kasozi |e investigator |4 oth | |
| 700 | 1 | |a Eriksen, Jaran |e investigator |4 oth | |
| 700 | 1 | |a Armour-Marshall, Jasmine |e investigator |4 oth | |
| 700 | 1 | |a Kellett, John |e investigator |4 oth | |
| 700 | 1 | |a Metcalfe, John Z |e investigator |4 oth | |
| 700 | 1 | |a Moore, Jolene |e investigator |4 oth | |
| 700 | 1 | |a Blixt, Jonas |e investigator |4 oth | |
| 700 | 1 | |a Langton, Josephine |e investigator |4 oth | |
| 700 | 1 | |a Mejia, Juan Gutierrez |e investigator |4 oth | |
| 700 | 1 | |a Silesky-Jiménez, Juan Ignacio |e investigator |4 oth | |
| 700 | 1 | |a Soni, Kapil Dev |e investigator |4 oth | |
| 700 | 1 | |a Kohne, Karl Martin |e investigator |4 oth | |
| 700 | 1 | |a Rowan, Kathryn |e investigator |4 oth | |
| 700 | 1 | |a Yokobatake, Kazuhiro |e investigator |4 oth | |
| 700 | 1 | |a Doi, Kent |e investigator |4 oth | |
| 700 | 1 | |a Rudd, Kristina E |e investigator |4 oth | |
| 700 | 1 | |a Akuamoah-Boateng, Kwame Asante |e investigator |4 oth | |
| 700 | 1 | |a Irestedt, Lars |e investigator |4 oth | |
| 700 | 1 | |a Losonczy, Lia I |e investigator |4 oth | |
| 700 | 1 | |a Zhang, Lina |e investigator |4 oth | |
| 700 | 1 | |a Kurland, Lisa |e investigator |4 oth | |
| 700 | 1 | |a Guinness, Lorna |e investigator |4 oth | |
| 700 | 1 | |a Bains, Lovenish |e investigator |4 oth | |
| 700 | 1 | |a Nyaika, Margaret |e investigator |4 oth | |
| 700 | 1 | |a Castegren, Markus |e investigator |4 oth | |
| 700 | 1 | |a Loftus, Matthew |e investigator |4 oth | |
| 700 | 1 | |a Reinikainen, Matti |e investigator |4 oth | |
| 700 | 1 | |a Cox, Megan |e investigator |4 oth | |
| 700 | 1 | |a Mer, Mervyn |e investigator |4 oth | |
| 700 | 1 | |a Jaung, Michael |e investigator |4 oth | |
| 700 | 1 | |a Lipnick, Michael S |e investigator |4 oth | |
| 700 | 1 | |a English, Mike |e investigator |4 oth | |
| 700 | 1 | |a Lipcey, Miklos |e investigator |4 oth | |
| 700 | 1 | |a Khajanchi, Monty |e investigator |4 oth | |
| 700 | 1 | |a Ulisubisya, Mpoki |e investigator |4 oth | |
| 700 | 1 | |a Nyirenda, Mulinda |e investigator |4 oth | |
| 700 | 1 | |a Halmin, Märit Amanda |e investigator |4 oth | |
| 773 | 0 | 8 | |i Enthalten in |t BMJ global health |d 2016 |g 6(2021), 9 vom: 21. Sept. |w (DE-627)NLM262254549 |x 2059-7908 |7 nnns |
| 773 | 1 | 8 | |g volume:6 |g year:2021 |g number:9 |g day:21 |g month:09 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1136/bmjgh-2021-006585 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 6 |j 2021 |e 9 |b 21 |c 09 | ||